Rani Therapeutics Holdings, Inc.

NASDAQ:RANI

1.07 (USD) • At close May 1, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 3.7624.2774.5147.3776.3644.9727.55218.98427.00727.21997.181107.839117.453129.74369.31476.66273.058
Short Term Investments 23.87726.12726.38732.70442.67555.55467.05467.80371.47570.9520000000
Cash and Short Term Investments 27.63930.40430.90140.08149.03960.52674.60686.78798.48298.17197.181107.839117.453129.74369.31476.66273.058
Net Receivables 0.4280000000000000000
Inventory 00000-0.2-0.20000000000
Other Current Assets 1.6771.9671.1331.8092.3082.6961.7682.2512.4422.5490.8121.4212.1422.6220.1650.140.167
Total Current Assets 29.74432.37132.03441.3950.54763.22276.37489.038100.924100.7297.993109.26119.595132.36569.47976.80274.945
Non-Current Assets:
Property, Plant & Equipment, Net 6.64410.92311.44611.8766.8237.2147.1337.4087.1036.9826.3516.0494.6124.5934.434.494.47
Goodwill 00000000000000000
Intangible Assets 00000000000000000
Goodwill and Intangible Assets 00000000000000000
Long Term Investments 0000000000.50000000
Tax Assets 00000000000000000
Other Non-Current Assets 0.2460.2460.2460.2460.5460000000003.4120.7850
Total Non-Current Assets 6.8911.16911.69212.1227.3697.2147.1337.4087.1037.4826.3516.0494.6124.5937.8425.2754.47
Total Assets 36.63443.5443.72653.51257.91670.43683.50796.446108.027108.202104.344115.309124.207136.95877.32182.07779.415
Liabilities & Equity:
Current Liabilities:
Account Payables 1.3591.5660.5060.8060.6481.4051.0371.5111.461.791.441.2651.081.3111.6670.9430.537
Short Term Debt 16.45917.58815.0169.8086.3332.011.7120.9232.0121.9681.3161.3003.8841.9461.359
Tax Payables 00000000000.358000000
Deferred Revenue 1.4370.600003.31100000003.4511.9612.717
Other Current Liabilities 2.0730.4571.0592.7611.0083.932.9862.7161.3433.4282.2351.5911.563.9393.8042.2363.412
Total Current Liabilities 19.89120.21116.58113.3757.9897.3455.7355.154.8157.1865.3494.1562.645.259.3557.0865.308
Non-Current Liabilities:
Long Term Debt 13.2517.55421.59525.60224.48428.27229.60329.70729.20814.4090.3410.5090001.8922.412
Deferred Revenue Non-Current 00000000000000000
Deferred Tax Liabilities Non-Current 00000000000000000
Other Non-Current Liabilities 00000000000000191.64191.57185.034
Total Non-Current Liabilities 13.2517.55421.59525.60224.48428.27229.60329.70729.20814.4090.3410.5091.080191.64193.462187.446
Total Liabilities 33.14137.76538.17638.97732.47335.61735.33834.85734.02321.5955.694.6652.645.25200.995200.548192.754
Equity:
Preferred Stock 0000000000000136.958191.64191.57185.034
Common Stock 0.0050.0050.0050.0050.0050.0050.0050.0050.0050.0050.0050.0050.0050.0051.4121.130.664
Retained Earnings -102.907-93.96-87.177-80.372-72.889-65.791-56.594-47.291-38.919-30.133-22.178-14.554-8.331-3.142-125.086-119.601-114.003
Accumulated Other Comprehensive Income/Loss 0.0050.008-0.005-0.011-0.012-0.041-0.063-0.01-0.073-0.057-0-0-0-136.958-0-192.70
Other Total Stockholders Equity 104.88997.06790.01287.77685.76283.3880.74678.01875.84272.37969.98667.93355.737-82.4550192.7-185.034
Total Shareholders Equity 1.9923.122.8357.39812.86617.55324.09430.72236.85542.19447.81353.38447.41151.366-123.674-118.471-113.339
Total Equity 3.4935.7755.5514.53525.44334.81948.16961.58974.00486.60798.654110.644121.567131.708-123.674-118.471-113.339
Total Liabilities & Shareholders Equity 36.63443.5443.72653.51257.91670.43683.50796.446108.027108.202104.344115.309124.207136.95877.32182.07779.415